Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Models, mechanisms and clinical evidence for cancer dormancy Aguirre-Ghiso JANat Rev Cancer 2007[Nov]; 7 (11): 834-46Patients with cancer can develop recurrent metastatic disease with latency periods that range from years even to decades. This pause can be explained by cancer dormancy, a stage in cancer progression in which residual disease is present but remains asymptomatic. Cancer dormancy is poorly understood, resulting in major shortcomings in our understanding of the full complexity of the disease. Here, I review experimental and clinical evidence that supports the existence of various mechanisms of cancer dormancy including angiogenic dormancy, cellular dormancy (G0-G1 arrest) and immunosurveillance. The advances in this field provide an emerging picture of how cancer dormancy can ensue and how it could be therapeutically targeted.|Animals[MESH]|Disease Progression[MESH]|Drug Resistance, Neoplasm[MESH]|Epigenesis, Genetic[MESH]|Humans[MESH]|Mice[MESH]|Mice, Inbred Strains[MESH]|Mice, Transgenic[MESH]|Models, Biological[MESH]|Neoplasm Invasiveness/physiopathology[MESH]|Neoplasm Metastasis/*physiopathology[MESH]|Neoplasm Proteins/physiology[MESH]|Neoplasm Recurrence, Local/physiopathology[MESH]|Neoplasm, Residual[MESH]|Neoplasms/blood supply/genetics/immunology/*pathology[MESH]|Neovascularization, Pathologic/physiopathology[MESH]|Time Factors[MESH]|Tumor Burden[MESH]|Tumor Escape[MESH] |
